We hypothesized that calcium and 1,2-diacylglycerols stimulated human neutrophfl (PMI~ protein kinase C (EC 2.7.1.37) in a me-step mechanism. The proposed mechanism entails (1) increx~ i~luMe protein kinase C activity and (2) endogenous protein phosphofflation, events which have not been biochemi¢~ dissociated. PMN which were treated with 100 nM ionomycin shifted protein kinase C activity from bch~g mostly soluble to insoluble. Concentrations of ionomyein greater than 300 nM stimulated a douMing of total cellular (soluble + insoluble) protein kinase activity and stimulated increased endogenous ~lation of PMN proteins, lntraceilular calcium (measured with fma-2) increased from 65 muM (lmsai) to 680 n.M using 500 nM ionomycin; calcium increases were dose-dependent. The antl-i~ agents acetylsalicylic acid and sodium saUcylate (but not ibuprophen, indomethacin or acetmninophen) inln'bited ionmnycin-induced protein kinase C activation and protein phosphorylafion in a d0se.4kpendent nmmm by inhibiting the production of diacylglyeerols, l.Olcoyl.2-acetylglycerol reversed the inhibitory effect of salicylates. In contrast to the effect of acetylsalicylates on lwotein kinase C functional activity the distribution of pherbel receptors was unaffected in acetylsalieylate.treatet[, ionomycin-stimulated I'MN using a ldmrbe~binding assay. Our results show that ionomycin increased intracellular diacylglyceml levels 3.5-fold over those present in control PMN, while acetylsalieylate decreased diacylglycerei production in ionomycin.stimulated PMN below baseline values. These results support the hypothesis that increased intracellular ¢aklum activated protein klnase C leading to protein phesphorylation in two distinct dlssoclable events: (I) increased intraeellular calcium; and (2) increased 1,2diaeylg~yeerol levels. Abbreviations: [Ca2+]i, intracellelar calcium concentration; DMSO, dimethyl s~'f3xide; H-7, 1-(5-isoquinolinsulfonyl-2-methylpiperazine hy&~c~oride); fura-2/AM, fura-2 aoetoxymethyl ester; OAG, [-oleoyl-2-acetyl-sn-glycerol; PDB, phorbol 12,13-dibutyrate; [3R]PDB, [20(n)-3H]phorbo! 12,13-dibutyrate; PIVlN, polymorpltonuclear leukocyte,s; SDS-PAGE, sodium dodecylsulfate polyacrylamide gel electropboresis.
il-itracellular pools. Calcium and phospholipid-dependent protein kinase has been described in many tissues [4] [5] [6] , and is found in both soluble (over 75% of the total cellular activity) and insoluble forms. Studies in rabbit polymorphonuclear leuko¢ytes (PMN) suggest that at least membrane-bound proteha ldnase C is regulated through a guanine ~,~deotide-dependent pathway [6L One ff~oposed protein kinase C aetivatic:: mechanism states that calcium and 1,2-diacylglycerols provide dual signals [7, 8] that stimulate protein kinase C to alter its solubility properties from mostly soluble to insoluble [4, 5, 9] . The change in protein kinase C solubility may be associated with its binding to four or more phospholipid residues (mostly phosphatidylserine) which are associated with cellular membranes [10] . It is unclear whether protein kinase C physically moves from the cytosol to membranes, or if protein kinase C 'translocation' merely reflects changes in enzyme activity which are,~.~sociated with specific cellular microenvironments..'['he existence of a calcium/phospholipid-independent form of protein kinase C [11, 12] and knowledge of genetically diff¢rent subsets of protein kin~se C [13, 14] demand that current models of protein kinase C activation be altered in order to accommodate the regulation of the different types of protein ldnase C, a multifunctional enzyme with at least 35 documented substrP, tes. Increased affinity of activated protein kinase C for cellular membranes may function to bring protein kinase C into close proximity with reported substrates, such as the receptors for epidermal growth factor insulin, and transferrin, the phosphorylation of which is correlated with the regulation of receptor endocytosis and selective receptor down-regulation [15] [16] [17] . With regard to the regulation of cellular activation, other enzymes axe reported to phosphorylate proteins which are also substrates of protein kinase C. For example, protein kinase C and myosin fight chain kinase both phosphorylate the 20 kDa light chain of myosin [18, 19] but at different amino-acid residues. In summary, these reports suggest the extreme complexity of interpreting results from studies attempting to define a role for protein phosphorylation by protein kinase C during PMN activation.
We now report that protein kinase C activation involves at least two steps which can be functionally separated into changes in the solubility of the enzyme's activity and changes in protein phosphorylation. Our results indicate that increased [Ca2+]i alone, if sufficiently high in concentration, can stimulate increased insoluble protein kinase C activity, but this observation does not always indicate that significant qualitative or quantitative changes in cellular phosphoproteins have occurred. A second stimulus involving diacylglycerol production is apparently required to activate membrane associated-protein kinase C to phosphorylate proteins within the ceil.
Materials and Methods
Cells. Human PMN were obtained from freshly drawn, whole blood by venipuncture of normal, healthy adult donors. The PMN were isolated by Ficoll/hypaque centrifugation, dextran sedimen-'~atio~ and hypotonic lysis of residual erythrocytes as described [20, 21] . Purified PMN were washed with 100 ram phosphate-buffered saline or 10 mM Hepes (pH 7.5) containing 10 mM magnesium and 0.5 mM calcium before use. Cells were greater than 97~ PMN by differential staining, and were greater than 95~ viable by the Trypan blue exclusion assay.
Materials. Ionomycin was obtained from Calbiochem (La Jolla, CA) and stored at 4 ° C as a 10 mg/ml (14 raM) stock solution in DMSO. H-7 was obtained from Seikagaku America (St. Petersburg, FL) and was diluted with the appropriate buffer from a 10 mM aqueous stock solution. The acetoxymethyl ester of fura-2 was purchased from 1~.~o!e,:_ubr Probes (Junction City, OR) and stored at -20°C as a 1 mg/ml stock solution. Radiolabeled compounds were obtained from Amersham (Arlington Heights, IL). Reagents used in electrophoresis were from Bio-Rad (Rockville Center, NY). All other reagents were obtained from Sigma (St. Louis, Me) unless otherwise stated. Protein concentrations were determined using the Pierce reagent (Pierce, Rockford, IL). lntracellular calcium measurements using fura.2. For these experiments, cells were isolated from whole blood using citric acid/dextrose. A 30 mi aliquot of fresh, non-heparinized blood was mixed with 6 ml of ACD (220 mM dextrose/200 raM trisod:,um citrate/140 mM citric a~id), plus 18 ml of 6% dextran/0.5% NaCI (Abbott Laboratories, Chicago, IL) and sedimented for 45 mi. Ln_ at room temperature. PMN-rich supernatant was centrifuged at 500 x g for 6 rain, and the resulting pellet was subjected to two rounds of hypotonic shock to lyse erythrocytes. The cellular pellet was mixed with 2 ml of 100 ram phosphate-buffered saline, layered onto 3 ml of Ficoll-Paque (Pharmacia, Piscataway, N J) and centrifuged at 850 x g for 20 min at 4 ° C. The final pellet contained mc,~ than 97% neutrophils and was used for the experiments described below. PMN at 5.107/ml were incubated for 25 rain at room temperature in 10 mM Hepes (pH 7.5), 150 mM NaCI, 3.0 nLM glucose, 5 mM KC1, 2 mM CaCl2, 1 mM MgCI 2 plus 5 pM fura-2/AM. Loaded cells were washed twice to remove unincorporated fura-2, and pre-warmed for 10 min at 37 ° C. Some cells were pre,warmed in calciumand magnesium-free loading buffer containing 2 mM EDTA. Intracellular calcium measurements were made u.,ing a Perkin-Elmer model 650-10S fluorescence spectrophotometer and a ¢ontinu. ously stirred cuvette. The reaction mixture contained 106 cells in 1 ml of loading buffer in the presence or absence of stimuli or inhibitors. Fura-2 fluorescence measurements were made at 500 nm emission and at both 340 nM and 380 nM excitation wavelengths [22] . Maximal fluorescence was obtained by permeabilizing the cells with 15 ~tg/ml digitonin, and minimal fluorescence was obtained by competing calcium from fura-2 with 2.5 mM MnCI 2. Calcium concentrations were derived from direct measurements of the spectrophotometric tracings using the following formula:
where R is the ratio of the fluorescence excitation measurements at 340 to 380 nm, Rn~ and Rm~ are the experimentally determined tni,imum and maximum calcium measurement ratios (340 nm to 380 nm), respectively, K d is the dissociation constant for rata-2, and B is a fixed dye calibration constant.
Cell treatment with ionomycin and salicylates. PMN were pre-warmed for 5 min at 5-10 6 cells/ml in either 100 mM phosphate-buffered saline or 10 mM Hepes (pH 7.4) plus 10 mM Mg 2+ and 500/~M Ca 2+. PMN were centrifuged and resuspended in pre-wm,'med buffer containing the appropriate concentration of ionomycin for 5 rain. At the end of the incubation period, I0 re',. of ice-cold buffer was added to the reaction vessel arid the cells were immediately centrifuged. For some experiments, PMN were first treated for 5 mi~ ,,:Ph 0.~3i-100 tiM concentrations of anti-inflammatory agents before treatment with ionomycin; anti-inflammatory agents were present throughout the incubation period.
Cell #actionation and protein kinase C assay. PMN were disrupted by sonication in homogenization buffer (50 mM Tris (pH 7.5), 50 taM 2-mercaptoethanol, 2 mM EDTA, 1 mM PMSF and 0.05~ Triton X-100) and centrifuged at 100000 x g for 60 min to prepare soluble and insoluble fractions, as previously described [23] . Aliquots of fractions were assayed for protein kinase C activity in vitro within 24 h of their preparation, as described [23, 24] , using histone type IIIS as a substrate. Assays were conducted to quantitate backgrcand phosphotransferase activity in the assay by measuring histone phosphorylation in the absence of calcium, activators and phospholipid; under these conditions, background activity was routinely less than 10~ of the total protein kinase C activity; total cellular protein kinase C activity was defined as the sum of the soluble and insoluble activities recovered from a single population of PMN treated as indicated. Negative control conditions consisted of assays at 4 or 40 o C, in the absence of sample (i.e., protein kinase C-containing material), or using sample which had been boiled for 3 mln before adding them to the assay. Positive control conditions included parallel assays using highly purified protein kinase C, or protein kinase C activity stimulated by 10 ng/ml phorbo112-myristate 13-acetate, a potent protein kinase C activator. Protein kinase C activity was calculated by subtracting both negative control and background activities, and is reported as pmol [32p]phosphate transferred to histone protein per rnin for 10-Tcells, +S.E.
[ 3H] Phorbol 12,13-dibutyrate.binding assays. Cellular phorbol ester receptors were quantitated in soluble and inr, oluble neutrophil fractions [25, 26] . To accomplish this, 100/zl of subcellular fraction (adjusted to 200 #g/m1 protein) were added to a mixture of 50 mM Tris-HCl (pH 7.5) 100 #g/ml phosphatidylserine, 1 mM CaCI2, 2 mg/ml bovine serum albumin and 100 nM [3HlPDB (19.7 [23, 24, 27 ] so as to maximize [32p]phosphate loading and mininuz" e both cellular activation which was caused by PMN adherence and background phosphorylation in resting PMN. PMN (10 s cells/condition) were incubated for 30 min at 25 °C in 100 mM phosphate-buffered saline containing 450/~M c,~.,:;.'.'.m and 250/~M magnesium for 30 min at 25" C. The medium was replaced with incubation buffer (6 mM Hepes (pH 7.45), 150 mM NaCI, 10 mM glucose, 5 mM KCI, 1 mM MgCI2, and 0.25-1 mCi [32P]phosphate) for 90-120 min at 20-25°C. The incubation buffer was replaced with glucose-free incubation buffer containing the indicated stimuli or inhibitors. At the end of the incubation period the buffer was quickly aspirated and replaced with ice-cold collection buffer (250 mM sucrose, 100 mM NaF, 10 mM EDTA, 2 mM PMSF, 10 ttg/ral soybean trypsin inhibitor, 10 /~g/ml leupeptin) to stop cellular metabolism. PMN were scraped from the dishes and total cellular protein was precipitated with 12.5% trichloroacetic acid, extracted with acetone, and dried under nitrogen.
Polyacrylamide gel dectrophoresis and autoradiography. Both intact PMN and fractions of PMN
homogenates were solubilized in sample buffer (62.5 mM Tris-HC1, 5% 2-mercaptoethanol, 10% glycerol, 2% SDS, and Bromphenol blue) and boiled for 3 rain. Samples (50-75/~g/'lane) were subjected to 10% SDS-polyacrylamide electrophoresis [28] using 160 x 200 mm slab gels. Gels were stained with 0.I% Coomassie brilliant blue R-250 and dried, and autoradiography was performed at -70 °C for 72 h using Kodak XAR. Omat film. Relative molecular weights were determined with respect tO the relative mobility of standard proteins electrophoresed in parallel lanes.
Quantitation of sn-l,2-diacylglycerols. Cellular 1,2-diacylglycerols were measured by modifying a previously published method [29] . PMN were treated with inhibitors and stimuli as described above. At the end of the treatment period the tube containing the cells was plunged into an ethanol/ solid CO2 slush bath and 3 vol. of chloroform/ methanol (1:2, v/v) were added to stop the reaction. An additional 1.0 ml of chloroform and 0.5 ml of 1.0 M NaCI were added, the tubes were vortexed, and the mixture was centrifuged at 500 x g for 5 min to separate the aqueous phase from the lipid-containing organic phase. A 5~/tl aliquot of the organic phase was dried under nitrogen and resuspended in 20/d of twice.recrystaHiTed octyl fl-D-glucoside/cardiolipin solution (7.5%/5 mM in 1.0 DETA?AC). The reaction mixture was completed by adding 50/tl of buffer (100 mM imidizole (pH 6.6), 100 mM NaCI, 25 mM magnesium, and I mM EGTA), 2 ~1 of fresh 100 mM dithiothreitol and 5 /~1 of diglyceride kinas¢ (Lipidex, Middleton, Wl). The reaction was initiated by adding 10 ~1 of 10 mM [¥-3~P]ATP (specific activity: 110000 dpm/nmol) and was allowed to proceed for 30 rain at room temperature. The reaction was stopped with 1.0 ml of chloroform/methanol (3:1, v/v) and the phases were partitioned hy centrifugation as described. A 500 #1 aliquot of the organic phase was dried under nitrogen and resuspended in chloroform. A 20/~1 aliquot of this mixture was spotted onto a Silica Gel 60 chromatography plate (pre-equi. librated with acetone) and was chromatographed using chloroform/methanol/acetic acid (65:!5:5, v/v). The plate was air dried and autoradiography performed for 6 h at -70 °C using Kodak XAR-Omat film. Densitometry of autoradiogram was performed using a Bio-Rad or a Helena Quick-Scan R & D densitometer; quantitation of the peak corresponding to 1,2-diacylglycerols was accomplished by subtracting background density and nonspeeific control density values from test densities. The relevant spots were scraped from wetted silica plates and radio. activity present in the samples was quantitated in 10 ml of Safety Solve (Research Products International, Mount Prospect, IL) by liquid s~ntillation counting.
Results in this study we investigated whether increased protein kinase C activity associated with changes in calcium-induced solubility and increased diaeylglycerol levels could be dissociated from increased phosphotraasferase activity. In order to measure changes in [Ca2+]i, PMN were loaded with fura.2 for 25 rain at room temperature, and the change in fluorescence spectra of the probe was measured after the addition of ionomycin, an ionophore which was used to raise [Ca2+]~. The results of these experiments are summarized in Fig. 1 . Under our assay conditions the basal [Ca2+]i was 65 nM. As little as 50 nM ionomycin caused a significant increase in [Ca2+]i, equilibrating at 210 nM after 25 s (Fig. 1, upper tracing) . lonomyein from 50 to 1000 nM caused a dose-dependent increase in [Ca2+]i, achieving a maximmn of" 680 nM at ~0~ nM ionomycin. Calcium remained elevated withi~ PMN, even after 10 rain from the point of addition of ionophore (data not shown). Similar results were obtained when identical measurements were made in loading buffe~ containing 2 raM EDTA (Fig. 1, lower tracing) , but maximal fluorescence changes were about 25~ lower at each concentration employed. These resuits reveal that mieromolar concentrations of ionomycin caused ~ dose-del~ndent increase in Changes in intraceflular calcium monitored using the fluorescent calcium probe, fura-2. PMN at 5.107/ml were loaded with 2.5 pM fura.2/AM at room temperature for 25 mm and then washed to remove the unincorporated probe. Fura-2 loaded PMN (106) in I ml loading buffer (upper tracings) or loading buffer without calcium but containing I raM EDTA (lower tracings) were mixed with the indicated concentration of ionomycin in a continuously stirring cuvette at 370C Continuous measurements of fura-2 fluore,.~'ncc changes were made at both 340 and 380 nm. Calcium concentrations indicated on the ordinate axis were derived from direct measurements of the tracings according to the [ormula described in Materials and Methods. lar stores, a finding which has been reported [30] [31] [32] .
Since protein kinase C activity is (by definition) Ca2+-dependent, we hypothesized that increased [Ca2+]i could stimulate protein kinase C activity. Heretofore, protein kinase C 'translocation' has been correlated with its activation; translocation has been defined as a relative increase in protein kinase C activity measured in the insoluble fraction of homogenized cells, resulting in that fraction corJtaining most of the cellular protein kinase C activity. This definition is somewhat in error because, as yet, the actual physical mobility of the enzyme from the cytoplasm to the plasma membrane has not been demonstrated (a phenomenon, therefore, which is inconsistent with the term). In fact, the precise subceUular distribution of the enzyme, as opposed to the distribution of enzymatic activity which is measured by the assay, is not known. Therefore, the term 'transloeation' will be avoided in the present report in lieu of more specific descriptions.
PMN were incubated with various concentrations of ionomycin for 5 rain at 37°C in order to increase [Ca2+]i . Soluble and insoluble fractions from treated PMN were assayed for protein kinase C activity. Less than I00 nM ionomycin had no significant effect on protein kinase C distribution (Table I) , but soluble protein kinase C activity doubled over the short concentration range. At concentrations of 100 nM or greater both increased insoluble protein kinase C activity and also a net loss of soluble activity was observed. Total cellular protein kinase C activity was defined as the sum of the protein kinase C activities recovered from soluble and insoluble fractions from a single ionomyein concentration. Concentrations of ionomycin up to 100 nM stimulated a small increase in total cellular protein kinase C activity (68~). Ionomycin at 300-5000 nM induced a statistically significant (P < 0.05) increase in total cellular activity, achieving a doubling at 300 nM. This unusual finding suggests that increased insoluble protein kinase C activity can be induced at concentrations of calcium lower than those which may stimulate activation of the enzyme.
Since increased [Ca2+]i induced chanf~es in the solubility of and quantitative changes ir,~ protein [27] . In addition, PMN were loaded with lower concentrations of radioisotope, for longer incubation times and at lower temperatures than commonly employed using adherence PMN [23, 24, 27] . These changes resulted in lower background interference on autoradiograms and lower phosphoprotein labeling in resting PMN, but produced more pronounced changes The numbers at the right represent the mobility of molecular weight standard proteins, Symbols designating phosphoproteins are explained in the text.
in phosphoproteins on autoradiograms of activated cells. PMN treated with 100 aM ionomycin for 5 min showed no appreciable changes in phosphoproteins (Fig, 2) , but 500 nM or greater concentrations of ionemycin induced increased density of phosphoprotein bands having relative mobilities near 200, 97, 80, 47, 39, 36, 34, 32, 20, 18 and 13 kD ( Fig. 2G; arrowheads) . Higher concentrations of ionomycin induced denser phosphorylation of existing proteins, and the appearance of several phosphoproteins which were previously unobserved but appeared to be relatively minor constituents. These results in~licate that moderate increases in [Ca'+]~ induce changes in the solubility of proteiti ~las~ C activity, and that higher [Ca2+]i cause changes in cellular phosphoproteins which may be a prerequisite for functional activation of PMN.
Since increased calcium concentrations probably activate several calcium-dependent phosphotransfer;ises, we were interested in characterizing which phosphoproteins, if an?,,, were sp~fi-cally generated by protein kinase C. [~2P]Phosphate-loaded PMb/were treated with 20/~M H-7 for 5 min, and then incubated with ionomycin. PMN pretreated with H-7 (Fig. 2, left panels) had fewer phosphoproteins than PMN treated without the inhibitor (Fig. 2, right panels) ; phosphoproteins which were observed at 200, 97, 80, 47, 39, 36, 18 and 13 kD were apparent in H-7 treated cells o,iy at the highest concentration of ionomycm employed (5.106 M; Fig. 2H, arrows) . H-7 reportedly inhibits protein kinase C in ad-dition to other enzymes. Therefore, these phosphoorotein changes suggest potential protein kir, ase C sabstrates, but do not offer proof because of ~he lack of specifioty of the inhibitor [33] . These results also suggest that changes in protein kinase C activity do not always indicate physiologica~ activation of the enzyme, as detmea by the phosphorylation of endogenous substrates.
The activation of protein kinase C in vivo requires both calcium and diacylglycerol [7, 8] Fig. 3 . Acetylsalicylic acid and sodium salicylate inhibited soluble protein kinase C activity in a dose-dependent manner. Insoluble protein kinase C activity from drug-treated PMN was not significant above background activity at any concentration tested. In a parallel study, acetaminophen, ibaprephen, and indomethacin used at similar concentrations had no significant effect on protein kinase C activity (data not shown). PMN were pre-treated with 10/~M acetylsalicylic acid or sodium salicylate for 5 rain and then incubated with various concentrations of ionomycin to increase [Ca2+]i. Protein kinase C activity in both the soluble and insoluble fractions of these PMN was largely inhibited (Fig. 4) , being significant above control levels (P < (3.05) only at concentrations gre:ater than I ~tM (which also caused a significant amount of lactate dehydrogenase release from the cytoplasm, indicating cell lysis; data ,'~ot shown). These results suggest that the ionomycin-induced increase in [Ca2+]i cannot be solely responsible fc, increased protein kinase C activity in human PMN. It is possible that protein kinase C solubility changed but was not measured by our protein kinase C activity assay system. To circumvent this problem, we measured PDB receptors in soluble and insoluble fractions using a PDB-binding assay (Table ii) . Resting PMN had 92~ of their total phorbol receptors associated with the soluble fraction. PMN treated with less than 300 nM ionomycin displayed a similar distribution, but cells treated with 300 nM or greater concentrations of ionomycin had a dose-dependent increase in the relative amount of PDB receptors associated with the insoluble fraction. A maximum of 89~ of the total cellular PDB receptors were found in the insoluble fraction using 1000 nM ionomycin. PMN treated with 1 /~M acetylsalicylic acid and then 500 nM had a distribution of PDB receptors similar to that of cells treated with ionomycin but without acetylsalicy= late. These data support the hypothesis that selective non-steroidal anti-inflammatory agents block protein kinase C activation but not changes in calcium-induced solubility. To strengthen our con- were treated with 2 /~M/ml OAG, a synthetic protein kinase C activator [35] . Acetylsalicylate (Fig. 5, lane D) blocked ionomycin-induced phosphorylation (Fig. 5, lane B) . In contrast, OAG (Fig. 5, lane E) reversed the acetylsalicylate-dependent inhibition of endogenous phosphoprotein formation. These results suggest that increased [Ca2+]i induces protein kinase C activation and protein phosphorylation by a mechanism which probably req-:..,e: !,2-a.2;~cy!~yccro! pzo~;:z'ion.
Discussion
Activation of protein kinase C in human PMN has been correlated with several specific functional eveag~, ~cluding chemotaxis, degranulation, O2-production and protein phosphorylation, of which are activated during inflammation. Several different classes of agents induce protein kinase C activation, including ligands of surface receptors such as epidermal growth factor [36] and transferrin [!1], lipophilic agents such as phorbol esters [4] and 1,2-diacylglycerols [ '7] , and bryostatin 1 [37] . Some of these agents also induce Significant changes in cellular phosphoproteins [23, 24, 27] which may provide a stimulatory signal.
Operationally, protein kinase C 'translocation' has been defined strictly on the basis of its solubility in certain buffers which sometimes contain varying concentrations of detergent and in cells disrupted by at least three different methods, a definition which does not indicate whether protein kinase C actually moves through the cytoplasm to membranes or if its activity is modulated in specific cellular microenvironments. The latter regulatory mechanism may be under the control of protein kinase C-I, the endogenous PMN inhibitor of protein kinase C [24] . Because conflicting reports currently exist, several models have been proposed to explain changes in the solubility of protein kinase C activity. One such model states that stimuli which elevate [Ca2+]i concomitantly increase protein kinase C binding to the lipid components of membranes [38] . Wolf et al. [38] found that the most favorable binding of protein kinase C to membranes occurred at [Ca2+]i approaching 500 nM. Our results agree favorably with those presented in their study indicating that concentrations of ionomycin which increase [Caa+] i to 500 nM ( Fig. 1 ) also stimulate increased insoluble protein kinase C activity (Table I) . Because activating most forms of protein kinase C is dependent upon caldum, we hypothesized that by increasing [Ca2+]i we would increase the enzyme's activity. In our experiments an increase in [Ca2+]i was correlated with higher levels of protein kinase C enzymatic activity. An increase in total activity has been reported [22, 39] , but this phenomenon is uncharacteristic of protein kinase C activity measurements using subcellular fractions, is highly .~ti~,lus-dependent, and most commonly a deer,~:ase in activity is observed [4, 40] . In support of our data are studies reporting that the calciumionophore A23187, although not as specific in its action, stimulated protein kinase C activation in PMN [41] and in monocytes [39] . In their study, Gopalakrishna ¢t at. [42] showed that protein kinase C binding to parietal yolk sac membranes is dependent not only on [Ca:+]i but also upon the sthaulus employed. Thus, it appears that increases in [Ca2+]i in some cases may be required to promote protein kinase C binding (or tighter binding) to less soluble cellular structures h order to initiate later functional responses in the PMN which could be activated by protein kinase C-dependent phosphorylation. Our results support that hypothesis because moderate changes in [CaZ+]i increased phorbol.binding in the insoluble fraction but higher concentrations were required to elicit phosphoprotein changes.
Although a calcium/phosphofipid.indepen&.~lt form of the protein kinase C has been reported [13, 17] , we found neither substantial phosphotransferase activity in the absence of calcium, diacylglycerol, and phospholipid, nor increased phorbol-binding in the soluble fraction after PMN treatment with ionomycin or OAG. Therefore, our results do not support the hypothesis that proteolyric cleavage of protein kinas¢ C is required for activation and subsequent phosphoprotein changes.
While the effect of non-steroidal anti-inflammatory drugs on PlVlN functions such as dogranulation and superoxide production are reasonably well documented [43, 44] , the spedfic mechanism of action of the drugs has remained elusive. Rationale for the effects of anti-inflammatory drugs in PMN include such explanations as their being free-radical scavengers [45] and inhibitors of cyclooxygenase activity [46, 47] . Bomalski and co-workers [34] have reported that acetylsalicylate inhibxted diacylglycerol production through phospholipase C. In our experiments, treatment of PMN ~ith acetylsalicylic acid and sodium salicyl~, "inhibited protein kinase C activity in the'insoluble fraction at all concentrations tested, but they inhibited soluble protein kinase C activity in a dose-dependent manner (Fig. 3) ; this may be explained by the disproportionate amounts of the enzyme in the two fractions. Similarly, these agents inhibited ionomycin-induced protein kinase C activity in a dose-dependent fashion (Fig. 4) , suggesting that the inhibition occurs at a point in the pa~way which is distal to increased [Ca2+]i. Since phospholipase C activity has been reported to reside in the plasma membrane (which is present in our insoluble fraction), it is possible that acetylsalicylic acid and sodium salicylate may inhibit phospholipase C activity and therefore diminish diacylslycerol production. Our data support this hypothesis because ionomycin alone increased 1,2-diacylglycerols 3.5-fold over those in resting PMH, and treatment with acetylsalicylate plus ionomycin resulted in control levels of diacylglycerols (Fig. 5) . The implications of these interesting preliminary results are curready under investigation in a more complete fashion, but the results indicate that acetylsaligly~ride inhibits the mass production of 1,2-diacylglycerol. More importantly, the addition of OAG reversed the effect of acetylsalicylic acid on ionomycin-induced prorein kinase C activity and protein phosphorylation (Fig. 6 ). Based on these results, it is likely that one of the inhibitory effects of acetylsalicylic acid may be through altering diacylglycerol p-'oduction.
In conclusion, our data indicate that increases in [CaZ+] i stimulate changes in the solubility of protein kinase C activity followed by its activation, the latter event being initiated by dia~lglycerol and leading to the phosphorylation of endogenous cellular protoins. In support or our observation, Lapetina et al. [48] found that the calcium-ionophore A23187 stimulated the phosphorylation of a 40 kDa platelet substrate of protein kinase C both in the presence and absence of acetylsalicylic acid; whereas ionomycin stimulated neither phospholipase C nor phosphoryla- tion of the 40 kDa protein in the presence of aspirin in platelets [49] . We also found that ionomycin treatment alone stimulated increased phosphorylation of at least 11 different proteins, of which five were blocked by pretreating PMN with the protein kinase C-inhibitor, H-7 ( Fig. 2) following protein kinase C activation,
